Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
Become a Member | Sign in
Home>News>This Article

Ariana Appoints Dr Mariana Kuras as Chief Technology Officer

Published: Wednesday, August 22, 2012
Last Updated: Wednesday, August 22, 2012
Bookmark and Share
CTO appointment reinforces senior management expertise in biomarker industry.

Ariana Pharma has announced that it has appointed Dr. Mariana Kuras as its chief technology officer.

Mariana brings to Ariana eight years of experience at Biosystems International.

Whilst director of research, she was responsible for the development and validation of biomarker platform technologies in multi-million euro projects.

These technologies included the application of antibodies to various diseases, including oncology and neurodegenerative diseases.

Mariana and her team contributed towards the development of thousands of antibodies used on microarrays and to the patenting and publication of biomarker signatures and paving their route to market.

As a genomics and bioinformatics scientist at Pfizer Global Research and Development, Fresnes, France, Mariana has also been responsible for genomic studies.

She has also been an independent scientific expert for the sixth and seventh framework of the European Commission and vice-chair for the life sciences panel for sixth PCRD of the research and training networks for the European Commission.

She was awarded a PhD in biophysics and computational biology from the University of Illinois at Urbana-Champaign, USA.

“Mariana brings an exceptional level of both industrial and scientific experience to Ariana,” said Dr. Mohammad Afshar, president and CEO of Ariana Pharma.

Dr. Afshar continued, “Demand for our biomarker activity has continued to increase dramatically as a result of the drive in life science industries to personalized medicine. Mariana’s unique hands-on experience of both computational and experimental aspects of biomarker development will be a key asset to Ariana. She will help Ariana continue to meet our client’s growing needs.”

“Ariana has become one of the most promising international players in diagnostic and personalized medicine,” said Dr. Mariana Kuras.

Dr. Kuras continued, “By providing a validated solution to the challenge of combining heterogenous data from multiple sources with patient characteristics, Ariana will continue to grow as industry demand continues to increase and I am looking forward to adding my experience to the Ariana effort.”

KEM® - or Knowledge Extraction and Management - is an association rules-based (non-statistical) analytical technology that finds patient responder sub-populations and biomarker signatures that statistical methods are unable to detect.

KEM optimizes clinical trial inclusion/exclusion criteria thereby lowering the number of patients needed to reach clinical endpoints and saving sponsors both time and money.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Ariana® Expands Operations to USA
Company also appoints James M. Shanahan VP business development of subsidiary “Ariana Data Intelligence, Inc.”
Monday, June 04, 2012
Scientific News
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Ancient Viral Molecules Essential for Human Development
Genetic material from ancient viral infections is critical to human development, according to researchers at the Stanford University School of Medicine.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
New Way to Force Stem Cells to Become Bone Cells
Potential therapies based on this discovery could help people heal bone injuries or set hardware, such as replacement knees and hips.
Promise of Newborn Stem Cells to Revolutionize Clinical Practice
In this article Shweta Sharma, PhD, discusses the potential of an Umbilical Cord Blood bank as an untapped source of samples for research and clinical trials.
New Anti-Malarial Drug Screening Model
University of South Florida researchers demonstrate novel chemogenomic profiling to identify drug targets for the most lethal strain of malaria.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos